Unison Advisors’s QuidelOrtho QDEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-4,864
Closed -$217K 184
2024
Q4
$217K Hold
4,864
0.03% 178
2024
Q3
$222K Buy
+4,864
New +$197K 0.03% 177
2024
Q2
Sell
-4,864
Closed -$233K 181
2024
Q1
$233K Hold
4,864
0.02% 174
2023
Q4
$358K Hold
4,864
0.04% 161
2023
Q3
$355K Hold
4,864
0.04% 160
2023
Q2
$403K Hold
4,864
0.04% 161
2023
Q1
$433K Hold
4,864
0.05% 145
2022
Q4
$417K Hold
4,864
0.05% 147
2022
Q3
$347K Buy
4,864
+1,112
+30% +$99.5K 0.06% 150
2022
Q2
$364K Hold
3,752
0.09% 126
2022
Q1
$421K Buy
+3,752
New +$400K 0.1% 121

Other funds holding QDEL

Unison Advisors's QDEL Position: Q1 2025 in Review

Unison Advisors sold out of QuidelOrtho (QDEL) in Q1 2025, closing a stake of 4,864 shares — an estimated $217K sold.

Unison Advisors first reported a position in QDEL in Q1 2022 and held it in 11 quarters. The position peaked at $433K in Q1 2023. 266 funds tracked by Wall St. Rank hold QDEL as of Q1 2025.

  • Unison Advisors reported no remaining QuidelOrtho position as of Q1 2025 after selling out during the quarter.
  • Unison Advisors sold 4,864 QuidelOrtho shares in Q1 2025, an estimated $217K.
  • Unison Advisors first reported a position in QuidelOrtho in Q1 2022 and held it in 11 quarters.
  • Unison Advisors's QuidelOrtho position peaked at $433K in Q1 2023.
  • 266 funds tracked by Wall St. Rank held QuidelOrtho as of Q1 2025.

Based on Unison Advisors's 13F filing for Q1 2025, filed 6 May 2025.